Low drug resistance to both platinum and taxane chemotherapy on anin vitrodrug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference21 articles.
1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008
2. Carcinoma of the ovary;Heintz;Int J Gynaecol Obstet,2003
3. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996
4. Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy;Loizzi;Am J Obstet Gynecol,2003
5. Chemotherapy sensitivity and resistance assays: a systematic review;Samson;J Clin Oncol,2004
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study;Current Oncology;2023-04-04
2. Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance;Oncology and Therapy;2023-04-04
3. Inhibition of LATS Kinases in Ovarian Cancer Activates Cyclin D1/CDK4 and Decreases DYRK1A Activity;2022-12-10
4. Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients;Medicina;2021-06-19
5. Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope;Nano-Micro Letters;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3